Literature DB >> 23542503

Amplification of antioxidant activity of haptoglobin(2-2)-hemoglobin at pathologic temperature and presence of antibiotics.

Masoumeh Tayari1, Danial Afsharzadeh.   

Abstract

It is clear that Haptoglobin binds to Hemoglobin strongly and irreversibly. This binding, protects body tissues against heme-mediated oxidative tissue damages via peroxidase activity of Haptoglobin-Hemoglobin complex. Peroxidase activity of Haptoglobin(2-2)-Hemoglobin complex was determined via measurement of following increase in absorption of produced tetraguaiacol as the second substrate of Haptoglobin-Hemoglobin complex by UV-Vis spectrophotometer at 470 nm and 42°C. The results are showing that peroxidase activity of Haptoglobin(2-2)-Hemoglobin complex is modulated by homotropic effect of hydrogen peroxide as the allosteric substrate. On the other hand, antioxidant activity of Haptoglobin(2-2)-Hemoglobin is increased via heterotropic effect of two antibiotics (especially ampicillin) on the peroxidase activity of the complex. The condition of pathologic temperature along with the administration of ampicillin and/or coamoxiclav is in favor of amplification in antioxidant activity of Haptoglobin(2-2)-Hemoglobin and combating against free radicals in individuals with Hp2-2 phenotype. Therefore, oxidative stress effects have been diminished in the population with this phenotype.

Entities:  

Keywords:  Antibiotics; Antioxidant; Haptoglobin; Hemoglobin; Pathologic

Year:  2011        PMID: 23542503      PMCID: PMC3358376          DOI: 10.1007/s12291-011-0181-8

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  21 in total

1.  Hemoglobin binding with haptoglobin: delineation of the haptoglobin binding site on the alpha-chain of human hemoglobin.

Authors:  D J McCormick; M Z Atassi
Journal:  J Protein Chem       Date:  1990-12

Review 2.  In vitro-in vivo scaling of CYP kinetic data not consistent with the classical Michaelis-Menten model.

Authors:  J B Houston; K E Kenworthy
Journal:  Drug Metab Dispos       Date:  2000-03       Impact factor: 3.922

3.  The binding of hemoglobin to haptoglobin and its relation to subunit dissociation of hemoglobin.

Authors:  R L Nagel; Q H Gibson
Journal:  J Biol Chem       Date:  1971-01-10       Impact factor: 5.157

4.  Studies on the reaction of haptoglobin with haemoglobin and haemoglobin chains. I. Stoichiometry and affinity.

Authors:  E Chiancone; A Alfsen; C Ioppolo; P Vecchini; A F Agrò; J Wyman; E Antonini
Journal:  J Mol Biol       Date:  1968-07-14       Impact factor: 5.469

Review 5.  Haptoglobin polymorphism and body iron stores.

Authors:  Joris R Delanghe; Michel R Langlois
Journal:  Clin Chem Lab Med       Date:  2002-03       Impact factor: 3.694

6.  Blood cell oxidative stress precedes hemolysis in whole blood-liver slice co-cultures of rat, dog, and human tissues.

Authors:  Alison E M Vickers; John R Sinclair; Robyn L Fisher; Stephen R Morris; William Way
Journal:  Toxicol Appl Pharmacol       Date:  2010-02-06       Impact factor: 4.219

7.  Structure-function analysis of the antioxidant properties of haptoglobin.

Authors:  M Melamed-Frank; O Lache; B I Enav; T Szafranek; N S Levy; R M Ricklis; A P Levy
Journal:  Blood       Date:  2001-12-15       Impact factor: 22.113

8.  The hemoglobin binding and activation by haptoglobins: spectrophotometric and potentiometric measurements.

Authors:  M Waks; A Alfsen
Journal:  Biochem Biophys Res Commun       Date:  1966-04-06       Impact factor: 3.575

9.  Hemoglobin. A biologic fenton reagent.

Authors:  S M Sadrzadeh; E Graf; S S Panter; P E Hallaway; J W Eaton
Journal:  J Biol Chem       Date:  1984-12-10       Impact factor: 5.157

10.  Haptoglobin is synthesized during granulocyte differentiation, stored in specific granules, and released by neutrophils in response to activation.

Authors:  Kim Theilgaard-Mönch; Lars C Jacobsen; Marianne J Nielsen; Thomas Rasmussen; Lene Udby; Maged Gharib; Peter D Arkwright; Adrian F Gombart; Jero Calafat; Søren K Moestrup; Bo T Porse; Niels Borregaard
Journal:  Blood       Date:  2006-03-16       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.